The Lancet Respiratory Medicine in conversation with
Un pódcast de The Lancet Group
156 Episodo
-
Yves Lacasse on long-term oxygen therapy for COPD
Publicado: 31/7/2022 -
Rachael Evans on living with long COVID
Publicado: 26/7/2022 -
Daniel Munblit and Dale Needham on core outcomes post-COVID-19
Publicado: 15/6/2022 -
Daiana Stolz on antibiotic stewardship in pneumonia
Publicado: 24/5/2022 -
Ablo Wachinou on sleep disordered breathing in Benin
Publicado: 8/4/2022 -
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID
Publicado: 7/4/2022 -
Dinh Bui on preterm birth and lung function deficits
Publicado: 18/2/2022 -
Ruvim Izĭckson on a joint flu and COVID-19 vaccine
Publicado: 31/1/2022 -
Wisia Wedzicha on a vaccine for COPD
Publicado: 11/1/2022 -
Eileen Rubin on patient-centered ARDS
Publicado: 30/12/2021 -
Daniel Altmann on COVID boosters
Publicado: 30/11/2021 -
Michael Kreuter on interstitial lung disease
Publicado: 6/9/2021 -
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19
Publicado: 20/8/2021 -
Charles Sprung and authors on end-of-life practices in ICUs globally
Publicado: 3/8/2021 -
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma
Publicado: 10/7/2021 -
Paul Verweij on COVID-19 associated aspergillosis
Publicado: 26/5/2021 -
Ignacio Rubio on COVID-19 pathophysiology and phenotypes
Publicado: 17/5/2021 -
Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia
Publicado: 14/5/2021 -
Fan Chung on chronic cough and long COVID
Publicado: 11/5/2021 -
Mepolizumab and the treatment of chronic rhinosinusitis
Publicado: 16/4/2021
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
